黑料官网

header-logo
GettyImages-609179959-hero
Pathology & Laboratory Medicine
Gustavo W. Leone, PhD

Gustavo W. Leone, PhD

Professor; Director, 黑料官网 Cancer Center; Senior Associate Dean of Cancer Research

Locations

  • CCC C5317

Contact Information

Education

Post-doctoral Training, Duke University Medical Center, 1994-1998
PhD, Virology, University of Calgary, 1994
BS, Biochemistry, University of Calgary, 1988

Biography

Gustavo W. Leone, PhD, started in his role as Director of the 黑料官网 Cancer Center, Senior Associate Dean of Cancer Research, and Professor of Biochemistry on April 15, 2020. Prior to his arrival at 黑料官网, Dr. Leone served as the Director of the NCI-designated Hollings Cancer Center at the Medical University of South Carolina from March 2017 to April 2020. Dr. Leone’s past research includes graduate work in biochemical and biophysical approaches to study protein function and virology (reovirus), with a specific emphasis on mechanisms of viral mediated entry into host cells. As a postdoctoral fellow at Duke University, he had the seminal finding linking Cyclin Dependent Kinases to the control of E2F transcription factors and regulation of the cell cycle.

Research Interests

Currently, Dr. Leone has an active research program that utilizes genetic models (cell-based systems, worms, and mice) to study Rb/E2F & PTEN signaling in the context of cell cycle control, endoreduplication, developmental biology and cancer (endometrial, liver, pancreatic, and breast cancers), as well as the genetics and biology of PTEN and the tumor microenvironment. Dr. Leone’s research group has made seminal contributions in two broad areas of research, one in the role of the Rb/E2F pathway in development and cancer, and the other in signaling between cells within the tumor microenvironment.

Publications

  • (Fang K, Ohihoin AG, Liu T, Choppavarapu L, Nosirov B, Wang Q, Yu XZ, Kamaraju S, Leone G, Jin VX.) Genome Med. 2024 Nov 18;16(1):134 PMID: 39558215 PMCID: PMC11572372 SCOPUS ID: 2-s2.0-85209564467 11/19/2024

  • (Zhou Y, He Z, Li T, Choppavarapu L, Hu X, Cao R, Leone GW, Kahn M, Jin VX.) Cancers (Basel). 2024 Jun 12;16(12) PMID: 38927910 PMCID: PMC11201718 SCOPUS ID: 2-s2.0-85197122887 06/27/2024

  • (Mora J, Romo R, Dempsey S, Silva B, Nevels D, Leone GW, Stolley M.) Cancer Causes Control. 2023 Dec;34(12):1037-1042 PMID: 37490139 SCOPUS ID: 2-s2.0-85165639290 07/25/2023

  • (Del Bufalo F, De Angelis B, Caruana I, Del Baldo G, De Ioris MA, Serra A, Mastronuzzi A, Cefalo MG, Pagliara D, Amicucci M, Li Pira G, Leone G, Bertaina V, Sinibaldi M, Di Cecca S, Guercio M, Abbaszadeh Z, Iaffaldano L, Gunetti M, Iacovelli S, Bugianesi R, Macchia S, Algeri M, Merli P, Galaverna F, Abbas R, Garganese MC, Villani MF, Colafati GS, Bonetti F, Rabusin M, Perruccio K, Folsi V, Quintarelli C, Locatelli F, Precision Medicine Team鈥揑RCCS Ospedale Pediatrico Bambino Gesù.) N Engl J Med. 2023 Apr 06;388(14):1284-1295 PMID: 37018492 04/06/2023

  • (George J, Li Y, Kadamberi IP, Parashar D, Tsaih SW, Gupta P, Geethadevi A, Chen C, Ghosh C, Sun Y, Mittal S, Ramchandran R, Rui H, Lopez-Berestein G, Rodriguez-Aguayo C, Leone G, Rader JS, Sood AK, Dey M, Pradeep S, Chaluvally-Raghavan P.) Cell Rep. 2023 Mar 28;42(3):112228 PMID: 36884347 PMCID: PMC10233815 SCOPUS ID: 2-s2.0-85149682952 03/09/2023

  • (Yu Z, Zhang L, Cattaneo P, Guimarães-Camboa N, Fang X, Gu Y, Peterson KL, Bogomolovas J, Cuitino C, Leone GW, Chen J, Evans SM.) Circulation. 2023 Jan 10;147(2):183-186 PMID: 36622904 PMCID: PMC9988404 SCOPUS ID: 2-s2.0-85145688465 01/10/2023

  • (Han L, Wu Y, Fang K, Sweeney S, Roesner UK, Parrish M, Patel K, Walter T, Piermattei J, Trimboli A, Lefler J, Timmers CD, Yu XZ, Jin VX, Zimmermann MT, Mathison AJ, Urrutia R, Ostrowski MC, Leone G.) Nat Commun. 2023 Jan 03;14(1):1 PMID: 36596776 PMCID: PMC9810714 SCOPUS ID: 2-s2.0-85145429848 01/04/2023

  • (Fong BC, Chakroun I, Iqbal MA, Paul S, Bastasic J, O'Neil D, Yakubovich E, Bejjani AT, Ahmadi N, Carter A, Clark A, Leone G, Park DS, Ghanem N, Vandenbosch R, Slack RS.) Cell Rep. 2022 Nov 01;41(5):111578 PMID: 36323247 SCOPUS ID: 2-s2.0-85140871739 11/03/2022

  • (Lefler JE, MarElia-Bennett CB, Thies KA, Hildreth BE 3rd, Sharma SM, Pitarresi JR, Han L, Everett C, Koivisto C, Cuitino MC, Timmers CD, O'Quinn E, Parrish M, Romeo MJ, Linke AJ, Hobbs GA, Leone G, Guttridge DC, Zimmers TA, Lesinski GB, Ostrowski MC.) Life Sci Alliance. 2022 Nov;5(11) PMID: 35803738 PMCID: PMC9270499 SCOPUS ID: 2-s2.0-85134426331 07/09/2022

  • (Corchado-Sonera M, Rambani K, Navarro K, Kladney R, Dowdle J, Leone G, Chamberlin HM.) G3 (Bethesda). 2022 Sep 30;12(10) PMID: 35929788 PMCID: PMC9526067 SCOPUS ID: 2-s2.0-85139433642 08/06/2022

  • (Wu J, Liu X, Reeser JAW, Trimboli AJ, Pécot T, Sizemore GM, Naidu SK, Fernandez SA, Yu L, Hallett M, Park M, Leone GW, Hildreth BE, Ostrowski MC.) Mol Cancer Res. 2022 Aug 05;20(8):1233-1246 PMID: 35533313 PMCID: PMC9357052 SCOPUS ID: 2-s2.0-85135596986 05/10/2022

  • (Han L, Seward C, Leone G, Ostrowski MC.) Adv Cancer Res. 2022;154:169-201 PMID: 35459469 SCOPUS ID: 2-s2.0-85127356799 04/24/2022

Publications of from the

© 2025 黑料官网.  All rights reserved.  | Terms and Privacy | Web Accessibility Statement

Non-Discrimination Statement
The 黑料官网 (黑料官网) is committed to fostering a diverse community of outstanding faculty, staff, and students, as well as ensuring equal educational opportunity, employment, and access to services, programs, and activities, without regard to an individual's race, color, national origin, religion, age, disability, sex, gender identity/expression, sexual orientation, marital status, pregnancy, predisposing genetic characteristic, or military status. Employees, students, applicants or other members of the 黑料官网 community (including but not limited to vendors, visitors, and guests) may not be subjected to harassment that is prohibited by law or treated adversely or retaliated against based upon a protected characteristic. 黑料官网’s policy as well as federal and state laws and regulations prohibit unlawful discrimination and harassment.

Notice of Compliance with Laws and Commitment to Civil Rights
The 黑料官网 is committed to full compliance with all applicable federal, state, and local laws and regulations in the pursuit of our missions. Consistent with recent federal guidance, we affirm our commitment to individual merit, fairness, and equal treatment in all aspects of academic and institutional decision-making. As part of this commitment, we are actively reviewing our policies and materials to ensure they align with federal nondiscrimination obligations.